Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Apr 2 2025 | Welcoming March's New HFSA Members HFSA News Membership Read More Apr 1 2025 | Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM Industry News In The News Industry Read More Mar 27 2025 | Highnoon Labs’ Commits to Advancing Heart Failure Care Through HFSA’s OMT-HF Certificate Program HFSA News Provider Education Read More Mar 27 2025 | BridgeBio to Present Cardiovascular Outcomes Data in Patients with Variant and Wild-type Transthyretin Amyloid Cardiomyopathy (ATTR-CM) from the ATTRibute-CM Study at the ACC Annual Scientific Sessions Industry News In The News Industry Read More Mar 19 2025 | Request for Proposal (RFP): Implementation of Artificial Intelligence (AI) in Cardiovascular Care Industry News In The News Industry Read More Pagination First page « First Previous page ‹ Previous … Page 21 Page 22 Page 23 Page 24 Current page 25 Page 26 Page 27 Page 28 Page 29 … Next page Next › Last page Last »
Apr 1 2025 | Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM Industry News In The News Industry Read More
Mar 27 2025 | Highnoon Labs’ Commits to Advancing Heart Failure Care Through HFSA’s OMT-HF Certificate Program HFSA News Provider Education Read More
Mar 27 2025 | BridgeBio to Present Cardiovascular Outcomes Data in Patients with Variant and Wild-type Transthyretin Amyloid Cardiomyopathy (ATTR-CM) from the ATTRibute-CM Study at the ACC Annual Scientific Sessions Industry News In The News Industry Read More
Mar 19 2025 | Request for Proposal (RFP): Implementation of Artificial Intelligence (AI) in Cardiovascular Care Industry News In The News Industry Read More
